These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A glimpse of the genetics of young-onset Parkinson's disease in Central Asia. Kaiyrzhanov R; Aitkulova A; Vandrovcova J; Murphy D; Zharkinbekova N; Shashkin C; Akhmetzhanov V; Kaishibayeva G; Karimova A; Myrzayev Z; Murray M; Khaibullin T; Hardy J; Houlden H Mol Genet Genomic Med; 2021 Jun; 9(6):e1671. PubMed ID: 33818904 [TBL] [Abstract][Full Text] [Related]
26. Genetics of Parkinson's disease--state of the art, 2013. Bonifati V Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S23-8. PubMed ID: 24262182 [TBL] [Abstract][Full Text] [Related]
27. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil. Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137 [TBL] [Abstract][Full Text] [Related]
28. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease. Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250 [TBL] [Abstract][Full Text] [Related]
29. Exonic rearrangements in the known Parkinson's disease-causing genes are a rare cause of the disease in South African patients. van der Merwe C; Carr J; Glanzmann B; Bardien S Neurosci Lett; 2016 Apr; 619():168-71. PubMed ID: 27001088 [TBL] [Abstract][Full Text] [Related]
30. Genetic screening of Filipinos suspected with familial Parkinson's disease: A pilot study. Caritativo ECA; Yu JRT; Bautista JMP; Nishioka K; Jamora RDG; Yalung PM; Ng AR; Hattori N Parkinsonism Relat Disord; 2023 Mar; 108():105319. PubMed ID: 36774704 [TBL] [Abstract][Full Text] [Related]
31. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ; Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347 [TBL] [Abstract][Full Text] [Related]
32. Heterozygote carriers for CNVs in PARK2 are at increased risk of Parkinson's disease. Huttenlocher J; Stefansson H; Steinberg S; Helgadottir HT; Sveinbjörnsdóttir S; Riess O; Bauer P; Stefansson K Hum Mol Genet; 2015 Oct; 24(19):5637-43. PubMed ID: 26188007 [TBL] [Abstract][Full Text] [Related]
34. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients. Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292 [TBL] [Abstract][Full Text] [Related]
35. Analysis of the genetic variability in Parkinson's disease from Southern Spain. Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746 [TBL] [Abstract][Full Text] [Related]
36. Rare and novel variants of PRKN and PINK1 genes in Vietnamese patients with early-onset Parkinson's disease. Ton ND; Thuan ND; Thuong MTH; Ngoc TTB; Nhung VP; Hoa NTT; Nam NH; Dung HT; Son ND; Ba NV; Bac ND; Tai TN; Dung LTK; Hung NT; Duong NT; Ha NH; Hai NV Mol Genet Genomic Med; 2020 Oct; 8(10):e1463. PubMed ID: 32856414 [TBL] [Abstract][Full Text] [Related]
37. Leveraging genetic diversity to understand monogenic Parkinson's disease's landscape in AfrAbia. Mohamed W Am J Neurodegener Dis; 2023; 12(4):108-122. PubMed ID: 37736165 [TBL] [Abstract][Full Text] [Related]
38. Genetics of Parkinson's disease in the Polish population. Milanowski ŁM; Ross OA; Friedman A; Hoffman-Zacharska D; Gorka-Skoczylas P; Jurek M; Koziorowski D; Wszolek ZK Neurol Neurochir Pol; 2021; 55(3):241-252. PubMed ID: 33539026 [TBL] [Abstract][Full Text] [Related]
39. Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson's study. Pachchek S; Landoulsi Z; Pavelka L; Schulte C; Buena-Atienza E; Gross C; Hauser AK; Reddy Bobbili D; Casadei N; May P; Krüger R; NPJ Parkinsons Dis; 2023 Nov; 9(1):156. PubMed ID: 37996455 [TBL] [Abstract][Full Text] [Related]